S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
NASDAQ:RXST

RxSight (RXST) Stock Forecast, Price & News

$26.75
-1.14 (-4.09%)
(As of 10/2/2023 ET)
Compare
Today's Range
$26.62
$27.90
50-Day Range
$26.75
$33.37
52-Week Range
$9.78
$33.77
Volume
264,382 shs
Average Volume
425,006 shs
Market Capitalization
$953.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.50

RxSight MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
14.0% Upside
$30.50 Price Target
Short Interest
Healthy
3.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of RxSight in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.84 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.66) to ($1.46) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

364th out of 975 stocks

Ophthalmic Goods Industry

6th out of 7 stocks


RXST stock logo

About RxSight (NASDAQ:RXST) Stock

RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RXST Price History

RXST Stock News Headlines

The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
RxSight (NASDAQ: RXST)
J.P. Morgan Sticks to Their Buy Rating for RxSight (RXST)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Where RxSight Stands With Analysts
RxSight's Earnings: A Preview
The Latest Analyst Ratings for RxSight
RxSight: Improved Margin Outlook
BTIG Keeps Their Buy Rating on RxSight (RXST)
See More Headlines
Receive RXST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter.

RXST Company Calendar

Last Earnings
8/07/2023
Today
10/02/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RXST
Fax
N/A
Employees
292
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.50
High Stock Price Forecast
$36.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+14.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-66,760,000.00
Pretax Margin
-88.67%

Debt

Sales & Book Value

Annual Sales
$49.01 million
Book Value
$3.24 per share

Miscellaneous

Free Float
28,112,000
Market Cap
$953.37 million
Optionable
Not Optionable
Beta
0.73
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Ronald M. Kurtz M.D. (Age 60)
    Pres, CEO & Director
    Comp: $1.03M
  • Ms. Shelley B. Thunen (Age 69)
    CFO & Assistant Sec.
    Comp: $651.36k
  • Dr. Ilya Goldshleger Ph.D. (Age 48)
    Chief Operating Officer
    Comp: $657.81k
  • Mr. Eric J. Weinberg (Age 62)
    Chief Commercial Officer
    Comp: $638.9k
  • Ms. Rebecca Williston
    VP of Accounting & Fin.
  • Mr. Matt Haller Ph.D.
    Chief Technology Officer
  • Alex Huang
    Investor Relations
  • Mr. Roy Freeman
    VP of Marketing
  • Ms. Caroline Vaughn
    VP of HR
  • Mr. Scott Gaines
    Sr. VP of Commercial Operations & Bus. Process













RXST Stock - Frequently Asked Questions

Should I buy or sell RxSight stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RxSight in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RXST shares.
View RXST analyst ratings
or view top-rated stocks.

What is RxSight's stock price forecast for 2023?

5 analysts have issued 12-month price objectives for RxSight's stock. Their RXST share price forecasts range from $20.00 to $36.00. On average, they expect the company's stock price to reach $30.50 in the next year. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for RXST
or view top-rated stocks among Wall Street analysts.

How have RXST shares performed in 2023?

RxSight's stock was trading at $12.67 at the beginning of the year. Since then, RXST stock has increased by 111.1% and is now trading at $26.75.
View the best growth stocks for 2023 here
.

Are investors shorting RxSight?

RxSight saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 1,060,000 shares, a decrease of 24.8% from the August 31st total of 1,410,000 shares. Based on an average daily trading volume, of 462,600 shares, the short-interest ratio is presently 2.3 days. Approximately 3.8% of the shares of the stock are sold short.
View RxSight's Short Interest
.

When is RxSight's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our RXST earnings forecast
.

How were RxSight's earnings last quarter?

RxSight, Inc. (NASDAQ:RXST) announced its quarterly earnings data on Monday, August, 7th. The company reported ($0.40) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.47) by $0.07. The firm had revenue of $20.81 million for the quarter, compared to analyst estimates of $19.21 million. RxSight had a negative net margin of 88.72% and a negative trailing twelve-month return on equity of 48.72%.

What ETF holds RxSight's stock ?

Invesco Dorsey Wright Healthcare Momentum ETF holds 53,792 shares of RXST stock, representing 1.07% of its portfolio.

What guidance has RxSight issued on next quarter's earnings?

RxSight updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $81.00 million-$86.00 million, compared to the consensus revenue estimate of $81.88 million.

When did RxSight IPO?

(RXST) raised $125 million in an initial public offering (IPO) on Friday, July 30th 2021. The company issued 7,350,000 shares at $16.00-$18.00 per share.

What is RxSight's stock symbol?

RxSight trades on the NASDAQ under the ticker symbol "RXST."

How do I buy shares of RxSight?

Shares of RXST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RxSight's stock price today?

One share of RXST stock can currently be purchased for approximately $26.75.

How much money does RxSight make?

RxSight (NASDAQ:RXST) has a market capitalization of $953.37 million and generates $49.01 million in revenue each year. The company earns $-66,760,000.00 in net income (profit) each year or ($1.99) on an earnings per share basis.

How many employees does RxSight have?

The company employs 292 workers across the globe.

How can I contact RxSight?

The official website for the company is www.rxsight.com. The company can be reached via phone at 949-521-7830 or via email at ir@rxsight.com.

This page (NASDAQ:RXST) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -